• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
NASDAQ Composite
Standard & Poors 500
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Johnson & Johnson (NY:JNJ)

270.47 +3.33 (+1.25%)
Official Closing Price Updated: 7:00 PM EST, Nov 20, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 11,925,382
Open 270.36
Bid (Size) 270.50 (120)
Ask (Size) 271.00 (520)
Prev. Close 267.14
Today's Range 269.47 - 272.50
52wk Range 199.91 - 290.25
Shares Outstanding 2,628,679,824
Dividend Yield 1.98%
Chart for  (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
Johnson & Johnson Delivered 'Immaculate' Prostate Cancer Data at ESMO. Here's Why Investors Should Care ↗
November 19, 2026
Johnson & Johnson's $3.05 billion Halda bet is already paying off in the clinic. 
Via The Motley Fool
Topics Artificial Intelligence
Dow Jones Losers Today: NIKE and UnitedHealth Lead Declines ↗
November 19, 2026
Via Chartmill
Topics Stocks

Performance

52-Week Range 6.8% below 52-week high
270.47
199.9152W Low 290.2552W High
1 Week 6.8% below 1-week high
264.681W Low 290.251W High

Johnson & Johnson (JNJ) traded between $199.91 and $290.25 over the past 52 weeks and last traded at $270.47, 6.8% below its 52-week high. Over the past week it ranged between $264.68 and $290.25.

Past 12 Months
-4.3%
+4.9%
+0.1%
+15.4%
+30.4%
+33.2%
1W -$12.08
1M +$12.69
3M +$0.23
6M +$36.13
YTD +$63.12
1Y +$67.40

JNJ was +33.2% over the past year, +15.4% over six months, +30.4% year to date, -4.3% in the last week.

12 Months vs Market
JNJ
+33.2%
DIA
+5.0%
SPY
+5.7%
QQQ
+3.9%
IWM
+12.0%

Over the past 12 months JNJ returned +33.2% versus DIA (Dow) +5.0%, SPY (S&P 500) +5.7%, QQQ (Nasdaq 100) +3.9% and IWM (Russell 2000) +12.0%.

Volume & Liquidity 1.63× 3-mo avg
Today 11,925,382 3-mo avg 7.3M
1W
9.4M
1M
7.8M
3M
7.3M
6M
7.7M
YTD
8.0M
1Y
8.0M

JNJ most recently traded 11,925,382 shares against a 3-month average daily volume of 7.3M.

More News

Read More
Dow Jones Decliners: UNH, NKE, CAT Lead Today's Session ↗
November 19, 2026
Via Chartmill
Topics Stocks
News headline image
Johnson & Johnson Announces First Commercial Installation of the OTTAVA™ Robotic Surgical System at Memorial Hermann Health System
November 19, 2026
From Johnson & Johnson
Via Business Wire
News headline image
Johnson & Johnson vs. Vertex Pharmaceuticals: Which Healthcare Stock Is a Better Buy for 2027? ↗
November 17, 2026
Via The Motley Fool
Johnson & Johnson (NYSE:JNJ): A Dividend Quality Case Study for Income Investors ↗
November 09, 2026
Via Chartmill
News headline image
2 of the Best Dividend Stocks to Buy With $5,000 in November ↗
November 17, 2026
Via The Motley Fool
Topics Intellectual Property
News headline image
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Johnson & Johnson - JNJ
November 17, 2026
From Pomerantz LLP
Via GlobeNewswire
News headline image
Johnson & Johnson vs. Pfizer: Consistency vs. Volatility in Revenue ↗
November 17, 2026
Via The Motley Fool
News headline image
Johnson & Johnson vs. Novo Nordisk: Steady Uptrend vs. Flat Revenue ↗
November 17, 2026
Via The Motley Fool
News headline image
Johnson & Johnson to acquire Ollin Biosciences and late-stage bispecific antibody with best-in-class potential in ophthalmology
November 16, 2026
From Johnson & Johnson
Via Business Wire
News headline image
5 Dividend Stocks to Buy and Hold Forever ↗
November 14, 2026
Via The Motley Fool
News headline image
These 5 Dividend Aristocrats® Have Raised Payouts for Decades ↗
November 11, 2026
Via The Motley Fool
Topics Economy
News headline image
Johnson & Johnson vs. Eli Lilly: Which Healthcare Giant's Stock Is a Better Buy for 2027? ↗
November 11, 2026
Via The Motley Fool
News headline image
Johnson & Johnson Sees a Path to Double-Digit Growth by 2030. Is the Dividend King a Buy? ↗
November 11, 2026
Via The Motley Fool
Topics Intellectual Property
News headline image
The AI Debt Bill Is Coming Due, But Biotech Has Revenue to Show for the Boom ↗
November 11, 2026
Via MarketBeat
Topics Artificial Intelligence Bankruptcy
News headline image
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Johnson & Johnson - JNJ
November 10, 2026
From Pomerantz LLP
Via GlobeNewswire
News headline image
Stocks Fell After the Midterms. History Says the Next 12 Months Could Be Very Different ↗
November 10, 2026
Via The Motley Fool
Topics Artificial Intelligence ETFs Economy
News headline image
Stock Market Sell-Off: Meet the Unstoppable Vanguard ETF Obliterating the S&P 500 in 2026 ↗
November 10, 2026
Via The Motley Fool
Topics Artificial Intelligence ETFs Economy
News headline image
The Buffett Indicator Is Flashing Red. These 3 Dividend Stocks Could Be Safe Havens. ↗
November 10, 2026
Via The Motley Fool
Topics Artificial Intelligence Economy
News headline image
4 Stocks I'm Not Selling Even If the Fed Keeps Raising Rates ↗
November 06, 2026
Via The Motley Fool
Topics Economy
News headline image
2 Growth Stocks to Buy in November Without Any Hesitation ↗
November 05, 2026
Via The Motley Fool
News headline image
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Johnson & Johnson - JNJ
November 03, 2026
From Pomerantz LLP
Via GlobeNewswire
News headline image
Worried About an AI Bubble? This ETF Could Be the Smartest Buy Right Now ↗
November 03, 2026
Via The Motley Fool
Topics Artificial Intelligence ETFs
News headline image
The Best Dividend Stocks to Buy With $5,000 in November ↗
November 02, 2026
Via The Motley Fool
Topics Artificial Intelligence Economy

Frequently Asked Questions

Is Johnson & Johnson publicly traded?
Yes, Johnson & Johnson is publicly traded.
What exchange does Johnson & Johnson trade on?
Johnson & Johnson trades on the New York Stock Exchange
What is the ticker symbol for Johnson & Johnson?
The ticker symbol for Johnson & Johnson is JNJ on the New York Stock Exchange
What is the current price of Johnson & Johnson?
The current price of Johnson & Johnson is 270.47
When was Johnson & Johnson last traded?
The last trade of Johnson & Johnson was at 11/20/26 07:00 PM ET
What is the market capitalization of Johnson & Johnson?
The market capitalization of Johnson & Johnson is 710.98B
How many shares of Johnson & Johnson are outstanding?
Johnson & Johnson has 711B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap